Az Üzleti Sajtószolgálat (Original Text Service - OTS) üzleti vállakozások, cégek, intézmények közleményeit, tájékoztatóit, meghívóit, állásfoglalásait közli. Szolgáltatásunk segítségével több mint 2000 újságírót és kommunikációs szakembert érhet el könnyen, gyorsan és költséghatékonyan – az Ön által megfogalmazott sajtóközleményt változtatás nélkül juttatjuk el az MTI-előfizetők szerkesztőségi rendszerébe vagy igény szerint akár a külföldi sajtóhoz is. (Az OTS anyagai nem képezik az MTI-kiadás részét, a szó szerint továbbított szövegekért minden esetben a közlő a felelős.)
|
|
|
2017. június 13., kedd 10:14 |
Rentschler Biotechnologie and Rentschler Fill Solutions announce strategic partnership for one-stop solutions with new state-of-the-art fill and finish facilities (part 1) |
|
Laupheim, Germany and Rankweil, Austria, June 13, 2017 (APA/OTS) - Rentschler Biotechnologie GmbH, a leading contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Rentschler Fill Solutions GmbH, an independent specialist for aseptic fill and finish services, today announced a strategic partnership to provide new state-of-the-art fill and finish facilities and one-stop solutions for biopharmaceutical products to meet the needs of Rentschler Biotechnologie's clients. Under the terms of the agreement, Rentschler Fill Solutions will prospectively serve as the exclusive partner for the fill and finish services of Rentschler Biotechnologie's manufacturing projects. Rentschler Fill Solutions is owned by the Rentschler family and will begin operations in mid-2018. In addition to servicing Rentschler Biotechnologie's clients, Rentschler Fill Solutions will offer its fill and finish services on a clinical as well as commercial scale to its own client base. |
"Based on the maturity of the biotech industry and demand for new
drugs in growing international markets, we are also seeing more and
more demand not only in terms of manufacturing for clinical studies
but for commercial-scale manufacturing and market supply. In order
to manage the expected growth and provide clients with new,
scalable, state-of-the art technologies and facilities, this new
partnership with Rentschler Fill Solutions, will allow us to meet
today´s and the future needs of our clients," Dr Frank Mathias, CEO
of Rentschler Biotechnologie, commented. "Rentschler Biotechnologie
is continually seeking and improving ways to help clients achieve
their goals, all along the value chain - from cell line development
through finished products. This partnership also supports our recent
strategic alliance with Leukocare, as improved formulation
strategies will contribute to the quality of the fill and finish
process. Both partnerships will enable us to serve our clients as
they grow."
At the Rentschler Fill Solutions facility in Austria,
state-of-the-art advanced aseptic filling technology will be
employed. Vials from DIN2R up to 50 mL can be used for the aseptic
filling of liquid or lyophilized biopharmaceuticals in small to
medium-sized batches. Up to 60,000 vials per batch can be filled.
Timelines and batch sizes can be tailored and flexibly scaled.
Standardized and aligned processes and packages enable fast-track
services while single-use equipment guarantees maximum product
safety. The Rentschler Fill Solutions facility complies with all
required regulatory standards and is designed to enable future
expansion without interrupting ongoing operations.
"Our state-of-the-art fill and finish facility has been designed to
deliver high quality products and reliable services to our clients.
As an independent specialist for the aseptic filling of liquid and
lyophilized biopharmaceuticals, we aim to manage the specific
filling requirements of a wide range of biopharmaceutical companies
from clinical studies through market supply," added Reinhold
Elsaesser, General Manager of Rentschler Fill Solutions. "We very
much look forward to working with Rentschler Biotechnologie to
address clinical and market needs in terms of capacity, scalability,
time to market, purity and safety. The clients of both companies
will benefit from reliable one-stop solutions and a fast time to
market based on our common commitment to quality and aligned
processes."
Rentschler Biotechnologie and Rentschler Fill Solutions will
introduce their partnership and service offering at the BIO
International Convention in hall C, booth 1929, taking place June
19-22 in San Diego, CA, USA. In addition, the LinkedIn page shows
the latest news from Rankweil:
www.linkedin.com/company/rentschler-fill-solutions-gmbh.
About Rentschler Biotechnologie GmbH
Rentschler Biotechnologie GmbH, located in Laupheim, Germany, is a
leading contract development and manufacturing organization (CDMO)
for bioprocess development and manufacturing of biopharmaceuticals
as well as for related consulting activities in terms of project
management and regulatory support. The Company's clients include
innovative biotech companies and major pharmaceutical companies
around the world. Many years of experience and excellence in finding
solutions as well as certified quality management and advanced
technologies ensure Rentschler's high quality standards. Rentschler
Biotechnologie is a family-owned company employing approximately 700
people. For further information, please visit www.rentschler.de.
About Rentschler Fill Solutions GmbH
Rentschler Fill Solutions GmbH, located in Rankweil, Austria, is an
independent contract manufacturing organization (CMO) for the
aseptic filling of liquid and lyophilized biopharmaceutical
products. The Company provides state-of-the-art facilities which
comply with the latest regulatory, quality and safety standards.
Rentschler Fill Solutions focuses on delivering small to
medium-sized batches (up to 60,000 vials per batch) to meet clinical
as well as market needs through all stages with its highly scalable
solutions. Rentschler Fill Solutions is a family-owned company with
a highly skilled team offering extensive experience and reliable
services in aseptic filling. Operations are planned to start in
mid-2018. For further information, please visit
www.rentschler-fill-solutions.com/en. (continues)
|
|
|
|
|
|
|
2017. június 13., kedd 10:15 |
Rentschler Biotechnologie and Rentschler Fill Solutions announce strategic partnership for one-stop solutions with new state-of-the-art fill and finish facilities (part 2) |
|
Laupheim, Germany and Rankweil, Austria, June 13, 2017 (APA/OTS) - |
About the Rentschler Biotechnologie and Rentschler Fill Solutions
partnership
The strategic partnership of Rentschler Biotechnologie and
Rentschler Fill Solutions provides clients with one-stop solutions
from gene to vial and unites two centers of excellence for the fast
and efficient bioprocess development, manufacturing and filling of
biopharmaceuticals with the Rentschler commitment to quality. Both
companies are owned by the Rentschler family, which has been a
trusted and successful partner in the pharmaceutical industry for
five generations. While the Companies remain independent of one
another, Rentschler Fill Solutions will serve as exclusive partner
for the fill and finish of Rentschler Biotechnologie's full-service
manufacturing projects.
Contact:
Rentschler Biotechnologie GmbH Dr. Marion Schrader Senior Director Company Communication marion.schrader@rentschler.de
Rentschler Fill Solutions GmbH Andrea Kitzelmann Expert Marketing andrea.kitzelmann@rentschler-fill-solutions.com
Media Inquiries:
MC Services AG rentschler@mc-services.eu
-------------------------------------------------------------------
Az OTS internetes oldalán található hírek, közlemények, fotók
a forrásmegjelöléssel (OTS) szabadon és korlátozás nélkül
felhasználhatók. Továbbközlés esetén a közzétevő köteles az átvett
anyagot tartalmának torzítása nélkül, félreérthetőséget,
rosszindulatú következtetéseket kizáró, az eredeti
szövegkörnyezetnek megfelelő módon feldolgozni és megjelentetni.
Az OTS hírek nem képezik az MTI hírkiadás részét, az MTI
által szó szerint továbbított tartalomért minden esetben a beadó a
felelős. © Copyright MTI nonprofit Zrt.
Az OTS szolgáltatással kapcsolatban további információt a
(06-1) 441-9050 telefonszámon vagy a ots@mti.hu elektronikus
levelező címen kaphat.
|
|
|
|
|
|
|
|
|
|
|